93 related articles for article (PubMed ID: 21374739)
1. Analysis of HP1α regulation in human breast cancer cells.
Thomsen R; Christensen DB; Rosborg S; Linnet TE; Blechingberg J; Nielsen AL
Mol Carcinog; 2011 Aug; 50(8):601-13. PubMed ID: 21374739
[TBL] [Abstract][Full Text] [Related]
2. Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells.
Vad-Nielsen J; Jakobsen KR; Daugaard TF; Thomsen R; Brügmann A; Sørensen BS; Nielsen AL
BMC Cancer; 2016 Jan; 16():32. PubMed ID: 26791953
[TBL] [Abstract][Full Text] [Related]
3. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
4. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
[TBL] [Abstract][Full Text] [Related]
7. Conserved properties of HP1(Hsalpha).
Norwood LE; Grade SK; Cryderman DE; Hines KA; Furiasse N; Toro R; Li Y; Dhasarathy A; Kladde MP; Hendrix MJ; Kirschmann DA; Wallrath LL
Gene; 2004 Jul; 336(1):37-46. PubMed ID: 15225874
[TBL] [Abstract][Full Text] [Related]
8. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.
Sharp JA; Mailer SL; Thomson PC; Lefèvre C; Nicholas KR
Mol Cancer; 2008 Jan; 7():1. PubMed ID: 18179684
[TBL] [Abstract][Full Text] [Related]
9. The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.
Lieberthal JG; Kaminsky M; Parkhurst CN; Tanese N
Breast Cancer Res; 2009; 11(3):R42. PubMed ID: 19566924
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
11. Reduced heterochromatin protein 1-beta (HP1beta) expression is correlated with increased invasive activity in human melanoma cells.
Nishimura K; Hirokawa YS; Mizutani H; Shiraishi T
Anticancer Res; 2006; 26(6B):4349-56. PubMed ID: 17201154
[TBL] [Abstract][Full Text] [Related]
12. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
Feldman RJ; Sementchenko VI; Gayed M; Fraig MM; Watson DK
Cancer Res; 2003 Aug; 63(15):4626-31. PubMed ID: 12907642
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
[TBL] [Abstract][Full Text] [Related]
14. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
15. Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.
Liu S; Stromberg A; Tai HH; Moscow JA
Mol Cancer Res; 2004 Aug; 2(8):477-87. PubMed ID: 15328374
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
18. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
